Hemotune is at the forefront of developing an innovative blood purification platform known as the HemoSystem, which leverages advanced biomedicine and nanotechnology. This system utilizes specially designed magnetic beads, referred to as HemoBeads, which are engineered to selectively bind to and remove large biomolecules, such as bacterial toxins and cytokines, from the bloodstream. The HemoSystem operates similarly to a dialysis machine, where the beads are mixed with the patient's blood, allowing for the targeted extraction of harmful compounds while ensuring that the beads themselves do not enter the patient's body. This approach enables multi-target precision medicine, offering a more effective treatment option for conditions like septic shock, which is often associated with immune suppression.

The technology behind Hemotune's HemoSystem is characterized by its high efficiency and selectivity, addressing the limitations of conventional blood purification methods that typically rely on filters or adsorber cartridges. The HemoBeads are designed with an ultra-magnetic core and non-sticky polymers, allowing them to be tailored for various therapeutic targets through the use of different affinity binders. This innovative platform not only aims to improve patient outcomes in critical conditions but also holds potential for broader applications in treating other diseases by selectively filtering harmful agents from the bloodstream. Hemotune's commitment to advancing this technology is underscored by recent funding successes, which will facilitate the transition from preclinical development to clinical trials.

Switzerland

We are a start-up medical device company originating from ETH Zurich and are passionate about developing life saving therapies.
Our mission is to develop a breakthrough medical device for the most urgent healthcare issues. Focusing on patients’ needs, we translate the most promising research to the clinics and ensure patient access to scientific progress as soon as possible. As pioneers we take courageous decisions and are shaping the future of medicine. We first focus on finding an efficient therapy for patients with sepsis, a devastating condition causing millions of deaths annually.

Hemotune

Company Details